Adaptyx is pioneering a programmable biowearable platform for continuous, multi-analyte molecular monitoring through a small wearable patch. At the core of Adaptyx’s technology are synthetic DNA-based molecular switches that enable continuous, lab-grade molecular sensing. This sensing capability powers the patch’s ability to collect and stream continuous biochemical data, supporting earlier interventions and more precise, AI-assisted care across both clinical and everyday health applications.
Adaptyx Biosciences had 19 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Adaptyx Biosciences had 4,553 followers as of October 12, 2026. The number of followers increased by 16 (0.35%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 20, 2025 | Seed Round | $14.00M | ― |
| Investor Name | Funding Round |
|---|---|
| Overwater Ventures | Seed Round |
| Hyperlink Ventures | Seed Round |
| Seaside Ventures | Seed Round |
| Interlagos | Seed Round |
| Stanford University | Seed Round |
| Humba Ventures | Seed Round |
| Starbloom Capital | Seed Round |
| Chan Zuckerberg Biohub | Seed Round |
A snapshot of private companies similar to Adaptyx Biosciences, helping you discover and navigate related company profiles.



